Skip to main content
Caplight Logo









CenSyn

CenSyn

Private
Scottsdale, ArizonaHealthcare & Life Scienceshttps://censyn.com

Last Round

Grant

Nov 15, 2023

Total Funding Raised

$529,970

Company Overview

CenSyn operates in Healthcare & Life Sciences and is based in Scottsdale, Arizona. Its latest recorded funding round was a Grant round in November 2023.

CenSyn is a medical technology company that is developing a portable electroencephalogram (EEG) device and an AI-enabled software platform to accelerate the diagnosis and monitoring of brain health-related disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CenSyn Comparables

Compare CenSyn with similar companies based on industry and business-model similarity.

CenSyn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioSignal Group Corp.
85%
Epitel, Inc.
80%
BrainScope
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CenSyn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 15, 2023
GrantMar 31, 2023
SeedDec 15, 2022
SeedSep 28, 2021
Pre SeedJan 19, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

CenSyn Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2023

    $275K grant round led by the National Science Foundation.

  • Dec 15, 2022

    Raised capital from 1517 Fund, Doctors for Health Innovation, and Sunstone Management.

Book a demo to see all signals

For institutional investors. Book with your work email.

CenSyn Filings

Explore SEC and related filing metadata, where available.

CenSyn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CenSyn's valuation, stock price, and market status.

Is CenSyn a public or private company?

CenSyn is a private company.

What is the current stock price of CenSyn?

CenSyn is a private company, so its shares have no public market price. Caplight tracks CenSyn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CenSyn worth (valuation)?

Valuation information for CenSyn is not publicly available.

Can I buy CenSyn stock?

CenSyn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CenSyn's last funding round?

CenSyn's most recent funding round was Grant on November 15, 2023.

Who are the main investors in CenSyn?

Key investors in CenSyn include Berkeley SkyDeck, Arizona Commerce Authority, National Science Foundation.

Will CenSyn IPO soon?

No public IPO plans have been announced for CenSyn.

How can I track CenSyn secondary market activity?

Caplight tracks bids, offers, and trades in CenSyn's shares on secondary markets.

Firmographic Details

HeadquartersScottsdale, Arizona
Employee Range3
Year Founded2019
Last FundingNov 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?